Clobex
Clobex
Generic Name
Clobex
Mechanism
Clobex (clobetasol propionate) is a super‑potent topical corticosteroid.
• Acts as a high‑affinity glucocorticoid receptor agonist.
• Inhibits phospholipase A₂, reducing arachidonic‑acid release and subsequent prostaglandin / leukotriene synthesis.
• Suppresses transcription of inflammatory cytokines (IL‑1, TNF‑α, IL‑6), chemokines, and adhesion molecules.
• Enhances dermal collagen synthesis and reduces vascular permeability, yielding rapid anti‑inflammatory and anti‑pruritic effects.
Pharmacokinetics
| Parameter | Description |
| Absorption | Very high local skin penetration; systemic absorption depends on dose, duration, and body surface area. |
| Distribution | Mainly confined to dermis‑epidermis; lipophilic, binds to plasma proteins when absorbed systemically. |
| Metabolism | Primary hepatic metabolism via CYP3A4/5 to inactive metabolites. |
| Elimination | Renal excretion; half‑life ≈ 12 h (topical). |
| Systemic exposure | Low when used appropriately; risk increases with large area, occlusion, or prolonged use. |
Indications
- Atopic dermatitis (moderate‑to‑severe).
- Psoriasis vulgaris – short bursts (≤ 7 days).
- Seborrheic dermatitis, cutaneous lupus erythematosus, sarcoidosis (localized).
- Vulvovaginal and perianal dermatitis (short courses).
- Keloid, hypertrophic scar – adjunctive therapy for reducing inflammation.
Contraindications
- Active skin infection (bacterial, fungal, or viral).
- Photosensitivity reactions – avoid concurrent photosensitizing agents.
- Hirsutism or androgen‑sensitive skin disorders – caution.
- Mucosal thinning or erosive lesions – contraindicated.
- Use in pregnancy – category C; limited data, use only if benefits outweigh risks.
Warnings:
• Systemic corticosteroid effects (hypothalamic‑pituitary‑adrenal suppression, hyperglycemia, hypertension).
• Skin atrophy, striae, telangiectasia, pigmentary changes.
• Delayed wound healing, increased infection susceptibility.
• Do not use on the face > 1–2 weeks in a row; limit facial use to ≤ 2 weeks total.
• Avoid use in children < 2 years; recommend caution in infants < 12 months.
Dosing
- Application: Apply a thin layer to affected areas once or twice daily.
- Duration:
- *Eczema/psoriasis*: 1–2 weeks; discontinue and taper if extended.
- *Vulvovaginal dermatitis*: 5–7 days.
- Occlusion: Do not cover the area with occlusive dressings for > 48 h unless prescribed.
- Children: Use with care; limit to ≤ 2 weeks and supervise for systemic signs.
- Pregnancy: Short courses may be considered; monitor fetal development if prolonged use.
Adverse Effects
| Category | Examples |
| Local | Skin thinning, striae, telangiectasia, acneiform eruptions, hyperpigmentation, hypopigmentation. |
| Systemic | HPA axis suppression, Cushingoid features, hyperglycemia, hypertension, adrenal crisis (rare). |
| Other | Allergic contact dermatitis, paradoxical rebound flare upon abrupt withdrawal. |
Monitoring
- Visual inspection of skin every 2–4 weeks for atrophy, striae, pigment changes.
- Pulse, blood pressure, and fasting glucose in patients with diabetes or hypertension.
- Pregnancy: Ultrasound if prolonged (> 4 weeks) use.
- Baseline labs (CBC, CMP) if systemic absorption suspected (large BSA, occlusion, prolonged therapy).
- Adrenal function (cosyntropin stimulation test) if tapering after > 4 weeks of use.
Clinical Pearls
- Short, high‑intensity bursts are most effective for psoriasis; prolonged application rarely improves outcomes and increases systemic exposure.
- Use micro‑dose (thinner layer) when treating sensitive areas (face, genitals) to mitigate atrophy risk.
- Rotating to a lower‑potency steroid after initial control helps prevent rebound and preserves dermal integrity.
- Co‑treat with moisturizers to maintain skin barrier and reduce dryness.
- Avoid comedogenic vehicles (e.g., petroleum jelly) that can trap the drug and amplify systemic absorption.
- Patient education: Emphasize “do not over‑apply” and “do not use on broken skin” to prevent infections.
--
• *Clobex (clobetasol propionate) is a high‑potency topical corticosteroid that provides rapid anti‑inflammatory benefit for a range of dermatoses when used judiciously. Monitoring for skin atrophy and systemic effects ensures safe, effective treatment.*